ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/381968408a467e86507531b7cb02d169.pdf
Abstract Title
ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS
First Name *
Robert
Last Name *
Schmouder
Co-author 1
Kenneth Kulmatycki kenneth.kulmatycki@novartis.com Novartis Institutes of BioMedical Research Pharmacokinetic Science Cambridge
Co-author 2
Elise Burmeister Getz elise.burmeister-getz@novartis.com Novartis Institutes of BioMedical Research Pharmacokinetic Science Emeryville
Co-author 3
Wendy Weiss wendy.weis@novartis.com Novartis Pharmaceuticals Corporation Clinical Trial Lead East Hanover
Co-author 4
Bharti Shah bharti.shah@novartis.com Novartis Pharmaceuticals Corporation Pharmacokinetic Science East Hanover
Co-author 5
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
E-Poster Format Requirements
PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but
must be saved and submitted as PDF file
.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos